Rituximab to treat gemcitabine-induced hemolytic–uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review
Crossref DOI link: https://doi.org/10.1007/s00280-016-3123-6
Published Online: 2016-08-06
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ritchie, Georgia E.
Fernando, Mangalee
Goldstein, David
License valid from 2016-08-06